Cargando…
An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation
An aerosol formulation containing 7.5 mg of R-salbutamol sulfate was developed. The aerosol was nebulized with an air-jet nebulizer, and further assessed according to the new European Medicines Agency (EMA) guidelines. A breath simulator was used for studies of delivery rate and total amount of the...
Autores principales: | Zhang, Xuemei, Liu, Qing, Hu, Junhua, Xu, Ling, Tan, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590724/ https://www.ncbi.nlm.nih.gov/pubmed/26579368 http://dx.doi.org/10.1016/j.apsb.2013.12.010 |
Ejemplares similares
-
Formulation of inhalable lipid-based salbutamol sulfate microparticles by spray drying technique
por: Daman, Zahra, et al.
Publicado: (2014) -
Co-spraying of carriers (mannitol-lactose) as a method to improve aerosolization performance of salbutamol sulfate dry powder inhaler
por: Ferdynand, Mickey Socrates, et al.
Publicado: (2020) -
Aerosol Characteristics and Physico-Chemical Compatibility of Combivent(®) (Containing Salbutamol and Ipratropium Bromide) Mixed with Three Other Inhalants: Budesonide, Beclomethasone or N-Acetylcysteine
por: Zhang, Rui, et al.
Publicado: (2020) -
Formulation and Development of Metered Dose Inhalations of Salbutamol in Solution Form
por: Khale, Anubha, et al.
Publicado: (2011) -
Compatible Stability and Aerosol Characteristics of Atrovent(®) (Ipratropium Bromide) Mixed with Salbutamol Sulfate, Terbutaline Sulfate, Budesonide, and Acetylcysteine
por: Chen, Yiting, et al.
Publicado: (2020)